Investors bullish on these stocks following latest development: America Movil S.A.B. de C.V. (AMX) and AstraZeneca PLC (AZN)

The recent price movement of AMX means that it is now down by -3.21% from its 52-week high and 33.08% up against its 52-week low prices. Over the past one week, the price volatility of AMX stands at 1.89% while the volatility over the past one month is 1.86%. The beta score for this stock is 0.49. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.

The company on 10/15/2019 published its latest quarterly earnings, with the report showing that the company recorded 0.16 earnings per share (EPS) during that period. This report was below the expectations of analysts of 0.27 by -0.11. The revenue by the firm was 13.45B for the quarter.

The shares of America Movil S.A.B. de C.V. (AMX) dropped by -0.25%, leading to a loss of -$0.04 per share, and saw AMX end the trading session at $15.97 on Thursday 11/07/19. AMX started the trading session at $15.97, before reaching a daily high of $16.10. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $15.89.

The trading volume on Thursday stood at 1509496, which was below the stock’s 3-month average volume of 2.38 million shares, out of a total 1.69B shares. As the price of the stock dipped, the market valuation of the company dropped to 52.26 billion.

The shares of AstraZeneca PLC (NYSE: AZN) went down by -1.14% by the end of the recent trading session. This movement saw its price plunge to close at $46.80, which was lower than the previous closing price of $47.34. Over the past one week, the price of AZN has slipped by -4.55%, while it has recorded a gain of 7.83% over the past one month. Its three-month performance saw AZN gain 4.53% while its six-month performance saw it surge by 24.30%. The situation is different though over the past one year, as the stock price went up by 22.00%, while its year-to-date (YTD) price performance jumped by 23.22%. The stock price has gone up by +10.93% compared to its 90-day low, while it is down -4.91% compared to its 90-day high price.

Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Buy. In the short-term, the stock has a 20-day average volume of 3,211,365 shares, with the short-term indicators averagely rating the stock as a 100% Buy. A look at its medium-term indicators reveals that it has a 50-Day average volume of 3,285,678 shares and the indicators have an average rating of 100% Buy. The last indicators, the long-term see AZN stock with a 100-Day average volume of 3,196,121 shares, giving it an average rating of 100% Buy. A look at the general picture of all short, medium and long-term indicators leaves AZN with an average rating of 100% Buy.

Several brokerage firms sent out their reports AZN stock not long ago. In its report sent out on October 25, 2019, Liberum lowered its ratings on AZN from a Hold to a Buy. In an earlier report on April 02, 2019, UBS Downgrade the stock from a Neutral to a Sell. Exane BNP Paribas meanwhile in its report on February 05, 2019 Initiated its rating of the stock to “Outperform”.

In related news to the company’s stock, around 18.80% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 601 institutions currently hold the AZN stock. In the last quarter, a 466,652,017 AZN shares were in the possession of institutions. On the other hand, the company recorded 54 new institutions who bought it their stock, while 55 institutions sold their entire AZN reserve. Of the current institutions investing in the stock, 246 increased their investment while 248 decreased their investment in the stock.